Cliff Asness’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $677M | Sell |
1,278,935
-74,902
| -6% | -$34.6M | 0.24% | 79 |
|
|
2026
Q1 | $634M | Buy |
1,353,837
+4,134
| +0.3% | +$2.12M | 0.29% | 59 |
|
|
2025
Q4 | $758M | Buy |
1,349,703
+324,293
| +32% | +$184M | 0.4% | 38 |
|
|
2025
Q3 | $518M | Buy |
1,025,410
+404,226
| +65% | +$176M | 0.33% | 51 |
|
|
2025
Q2 | $193M | Buy |
621,184
+81,637
| +15% | +$24.5M | 0.16% | 166 |
|
|
2025
Q1 | $158M | Buy |
539,547
+59,361
| +12% | +$20M | 0.16% | 158 |
|
|
2024
Q4 | $160M | Buy |
480,186
+114,436
| +31% | +$38.8M | 0.21% | 112 |
|
|
2024
Q3 | $121M | Buy |
365,750
+55,100
| +18% | +$20.9M | 0.17% | 147 |
|
|
2024
Q2 | $128M | Buy |
310,650
+119,257
| +62% | +$47.2M | 0.2% | 124 |
|
|
2024
Q1 | $77M | Sell |
191,393
-4,004
| -2% | -$1.41M | 0.13% | 185 |
|
|
2023
Q4 | $59.9M | Buy |
195,397
+12,087
| +7% | +$3.26M | 0.11% | 224 |
|
|
2023
Q3 | $44.4M | Buy |
183,310
+65,614
| +56% | +$16.8M | 0.09% | 268 |
|
|
2023
Q2 | $27.8M | Buy |
117,696
+10,783
| +10% | +$2.24M | 0.06% | 375 |
|
|
2023
Q1 | $19.7M | Buy |
106,913
+71,655
| +203% | +$14.8M | 0.04% | 471 |
|
|
2022
Q4 | $7.44M | Sell |
35,258
-65,977
| -65% | -$13.2M | 0.02% | 736 |
|
|
2022
Q3 | $15.9M | Sell |
101,235
-93,418
| -48% | -$14.9M | 0.04% | 518 |
|
|
2022
Q2 | $28.8M | Sell |
194,653
-20,003
| -9% | -$2.9M | 0.07% | 376 |
|
|
2022
Q1 | $35.1M | Buy |
214,656
+101,466
| +90% | +$16.7M | 0.07% | 341 |
|
|
2021
Q4 | $24.6M | Sell |
113,190
-12,600
| -10% | -$2.64M | 0.04% | 433 |
|
|
2021
Q3 | $23.8M | Buy |
125,790
+19,999
| +19% | +$3.65M | 0.04% | 435 |
|
|
2021
Q2 | $18.7M | Sell |
105,791
-14,201
| -12% | -$2.45M | 0.03% | 518 |
|
|
2021
Q1 | $19.7M | Buy |
119,992
+29,311
| +32% | +$4.48M | 0.03% | 505 |
|
|
2020
Q4 | $12.3M | Buy |
90,681
+36,279
| +67% | +$4.57M | 0.02% | 570 |
|
|
2020
Q3 | $6.08M | Sell |
54,402
-47,568
| -47% | -$5.5M | 0.01% | 732 |
|
|
2020
Q2 | $9.48M | Sell |
101,970
-39,639
| -28% | -$3.37M | 0.02% | 645 |
|
|
2020
Q1 | $10.4M | Buy |
141,609
+2,671
| +2% | +$232K | 0.02% | 614 |
|
|
2019
Q4 | $11.7M | Sell |
138,938
-71,203
| -34% | -$5.51M | 0.01% | 710 |
|
|
2019
Q3 | $17.7M | Sell |
210,141
-208,207
| -50% | -$15.7M | 0.02% | 625 |
|
|
2019
Q2 | $27.4M | Sell |
418,348
-8,888
| -2% | -$512K | 0.03% | 521 |
|
|
2019
Q1 | $25.2M | Sell |
427,236
-17,781
| -4% | -$1.06M | 0.03% | 556 |
|
|
2018
Q4 | $23.6M | Buy |
445,017
+278,000
| +166% | +$15.3M | 0.03% | 526 |
|
|
2018
Q3 | $10M | Buy |
167,017
+128,217
| +330% | +$7.01M | 0.01% | 784 |
|
|
2018
Q2 | $1.67M | Buy |
38,800
+94
| +0.2% | +$3.8K | ﹤0.01% | 1508 |
|
|
2018
Q1 | $1.35M | Buy |
+38,706
| New | +$1.41M | ﹤0.01% | 1539 |
|
Other funds holding MEDP
WA
Cliff Asness's MEDP Position: Q2 2026 in Review
Cliff Asness reduced its Medpace (MEDP) stake by 5.5% in Q2 2026, selling an estimated $34.6M and leaving 1,278,935 shares worth $677M. The position accounts for 0.24% of the portfolio, ranked #79.
Cliff Asness first reported a position in MEDP in Q1 2018 and has held it in 34 quarters since. The position peaked at $758M in Q4 2025. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Cliff Asness held 1,278,935 shares of Medpace worth $677M as of Q2 2026.
- Cliff Asness sold 74,902 Medpace shares in Q2 2026, an estimated $34.6M.
- Medpace made up 0.24% of Cliff Asness's portfolio in Q2 2026, its #79 holding.
- Cliff Asness first reported a position in Medpace in Q1 2018 and has held it in 34 quarters since.
- Cliff Asness's Medpace position peaked at $758M in Q4 2025.
- 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.